Cargando…
So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development
BACKGROUND: A sense of urgency exists to develop vaccines against SARS CoV-2, responsible for numerous global cases and deaths, as well as widespread social and economic disruption. Multiple approaches have been proposed to speed up vaccine development, including accelerated randomized controlled tr...
Autores principales: | Grady, Christine, Shah, Seema, Miller, Franklin, Danis, Marion, Nicolini, Marie, Ochoa, Jorge, Taylor, Holly, Wendler, Dave, Rid, Annette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418641/ https://www.ncbi.nlm.nih.gov/pubmed/32826103 http://dx.doi.org/10.1016/j.vaccine.2020.08.017 |
Ejemplares similares
-
Ethical trade-offs in vaccine development and distribution—Response to Gurwitz
por: Rid, Annette, et al.
Publicado: (2021) -
Is SARSCoV-2 nasopharyngeal swab still a gold standard in children?
por: Marino, Silvia, et al.
Publicado: (2020) -
Impact of liver enzymes on SARSCoV-2 infection and on the severity of clinical disease
por: Servín-Caamaño, A., et al.
Publicado: (2020) -
Exploring the acceptability of controlled human infection with SARSCoV2—a public consultation
por: Gbesemete, D., et al.
Publicado: (2020) -
Aspartate aminotransferase as predictor of severity in SARSCoV-2 infection: linear regression model
por: Servín-Caamaño, A., et al.
Publicado: (2020)